Simplex Trading
DRTS icon

Simplex Trading’s Alpha Tau Medical DRTS Stock Holding History

Simplex Trading’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12K Buy
+300
New +$2.12K ﹤0.01% 8354

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Simplex Trading's DRTS Position: Q1 2026 in Review

Simplex Trading sold out of Alpha Tau Medical (DRTS) in Q1 2026, closing a stake of 911 shares — an estimated $6.43K sold.

Simplex Trading first reported a position in DRTS in Q4 2025 and held it in 1 quarter. The position peaked at $4.51K in Q4 2025. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Simplex Trading reported no remaining Alpha Tau Medical position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 911 Alpha Tau Medical shares in Q1 2026, an estimated $6.43K.
  • Simplex Trading first reported a position in Alpha Tau Medical in Q4 2025 and held it in 1 quarter.
  • Simplex Trading's Alpha Tau Medical position peaked at $4.51K in Q4 2025.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.